|
End-of-day quote
Shanghai S.E.
2026-09-11
|
5-day change | 1st Jan Change | ||
| 14.02 CNY | -0.85% |
|
-4.82% | -6.97% |
| 09-02 | CICC Starts Tasly Pharmaceutical Group at Outperform with 17.80 Yuan Price Target | MT |
| 08-24 | Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 600535 Stock
- Consensus Tasly Pharmaceutical Group Co., Ltd
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
